Changes

(In USD millions, unless indicated otherwise)<ref>Novartis, [http://www.novartis.com/downloads/investors/reports/NovAR07-web-E.pdf "Key Performance Indicators"], ''2007 Novartis Annual Financial report'', page 61.(Pdf)</ref>

<table border===2007==="1"><tr>Total Group net sales: 39 800<th>Year</th> Continuing operations - <th>Net sales: 38 072</th> - Operating income excludingenvironmental and restructuring charges: 7 815 - Return on <th>R&D investments as a% of net sales (%): 20.5</th><th>Employees</th>- Operating income: 6 781</tr><tr>- Net income: 6 540<td>2007</td><td>39,800</td>Net income – Discontinued operations 5 428 377 Net income – Total Group 11 968 7 202 Basic earnings per share: - Continuing operations: 2.81 - Total Group: 5.15 R&D investments: 6 430 - As % of net sales: <td>16.9%</td> Number of associates: <td> 98 ,200 </td></tr><tr>'''<td>2006'''</td> Total Group net sales: <td>37 ,020</td> Continuing operations: - Net sales: 34 393 - Operating income excludingenvironmental and restructuring charges: 7 642 - Return on net sales(%): 22<td>15.2 - Operating income: 7 642 - Net income: 6 825 Net income – Discontinued operations: 377 Net income – Total Group: 7 202 Basic earnings per share: - Continuing operations1: 2.90 - Total Group: 3.06 R&D investments1: 5 321 - As % of net sales: 15.5</td> Number of associates: <td>94 ,241</td> For more information please view the 2007 Novartis Annual Financial report, found at: <ref/tr>[http://www.novartis.com/investors/index.shtml "2007 Novartis Annual Financial report"]</reftable>